ITRM
Closed
Iterum Therapeutics Plc
0.9746
-0.0204 (-2.05%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.995
Day's Range: 0.97 - 0.99
Send
sign up or login to leave a comment!
When Written:
0.9698
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company that focuses on developing and commercializing anti-infectives for patients with serious and life-threatening diseases. The company's lead product candidate is sulopenem, a novel oral and intravenous antibiotic for the treatment of uncomplicated urinary tract infections and complicated intra-abdominal infections. Iterum Therapeutics also has a pipeline of other anti-infective compounds in various stages of development. The company is headquartered in Dublin, Ireland, and has offices in Chicago, Illinois. Iterum Therapeutics is publicly traded on the NASDAQ stock exchange under the ticker symbol ITRM.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








